Literature DB >> 301894

Immunologic properties of protein-lipopolysaccharide complexes. I. Antibody response of normal, thymectomized, and nude mice to a lysozyme-lipopolysaccharide complex.

R J Scibienski, M E Gershwin.   

Abstract

The in vivo antibody response to the lysozyme component of a lysozyme-lipopolysaccharide complex has been investigated in normal, thymectomized and nude mice. The splenic PFC response elicited by the complex in CBA mice is 10- to 20-fold higher than the response elicited by lysozyme admixed with LPS. Both lysozyme-LPS complexes and lysozyme + LPS mixtures prime mice for a subsequent secondary anti-lysozyme response. In contrast, thymectomized mice responded poorly to lysozyme-LPS complexes unless reconstituted with splenic T cells. However, nude mice responded as well as Nu/+ controls to the complex. The PFC response of normal and of nude mice was severely depressed by treatment with anti-lymphocyte serum. These findings suggest that T lymphocytes contribute significantly to the enhanced immune responsiveness associated with LPS administration.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301894

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Down-regulation of immune responses to inhaled antigen: studies on the mechanism of induced suppression.

Authors:  J D Sedgwick; P G Holt
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

2.  Deficient antibody formation in the bone marrow of nude mice.

Authors:  R Benner; A van Oudenaren; J J Haaijman
Journal:  Immunology       Date:  1978-10       Impact factor: 7.397

3.  The immunoregulatory role of antigen-antibody complexes. I. Assessment of B and T-cell responses.

Authors:  S Kaattari; R J Scibienski; E Benjamini
Journal:  Immunology       Date:  1980-05       Impact factor: 7.397

4.  Induction of murine autoimmune disease by chronic polyclonal B cell activation.

Authors:  L Hang; J H Slack; C Amundson; S Izui; A N Theofilopoulos; F J Dixon
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.